Intraocular lens combinations

Information

  • Patent Grant
  • 6616692
  • Patent Number
    6,616,692
  • Date Filed
    Friday, September 3, 1999
    25 years ago
  • Date Issued
    Tuesday, September 9, 2003
    21 years ago
Abstract
Intraocular lens combinations are provided which include a first optic having a negative optical power and being adapted to be placed in a substantially fixed position in a mammalian eye. A second optic having a higher optical power than the first optic is provided. In addition, a movement assembly is provided which is coupled to the second optic and is adapted to cooperate with the eye to effect accommodating movement of the second optic in the eye. Very effective accommodation is provided with the present intraocular lens combination. The present combinations can be effectively positioned to effectively inhibit or reduce the risk of posterior capsular opacification (PCO).
Description




BACKGROUND OF THE INVENTION




The present invention relates to intraocular lens combinations. More particularly, the invention relates to intraocular lens combinations which are adapted to provide substantial benefits, such as accommodating movement and/or inhibition of posterior capsule opacification (PCO) in the eye.




The human eye includes an anterior chamber between the cornea and iris, a posterior chamber, including by a capsular bag, containing a crystalline lens, a ciliary muscle, a vitreous chamber behind the lens containing the vitreous humor, and a retina at the rear of this chamber. The human eye has a natural accommodation ability. The contraction and relaxation of the ciliary muscle provides the eye with near, intermediate and distant vision. This ciliary muscle action shapes the natural crystalline lens to the appropriate optical configuration for focusing light rays entering the eye on the retina.




After the natural crystalline lens is removed, for example, because of cataract or other condition, a conventional, monofocal IOL can be placed in the posterior chamber. Such a conventional IOL has very limited, if any, accommodating ability. However, the wearer of such an IOL continues to require the ability to view both near and far (distant) objects. Corrective spectacles may be employed as a useful solution. Recently, multifocal IOLs without accommodating movement have been used to provide near/far vision correction.




Attempts have been made to provide IOLs with accommodating movement along the optical axis of the eye as an alternative to shape changing. Examples of such attempts are set forth in Levy U.S. Pat. No. 4,409,691 and several patents to Cumming, including U.S. Pat. Nos. 5,674,282 and 5,496,366. The disclosure of each of these patents is incorporated herein by reference.




One problem that exists with such IOLs is that they often cannot move sufficiently to obtain the desired accommodation. The degree of accommodation has been closely related to the lens prescription of the individual patient. In addition, the presence of such lenses can result in cell growth from the capsular bag onto the optics of such lenses. Such cell growth, often referred to as posterior capsule opacification (PCO), can interfere with the clarity of the optic to the detriment of the lens wearer's vision.




It would be advantageous to provide IOLs adapted for accommodating movement, which can preferably achieve an acceptable amount of accommodation and/or a reduced risk of




SUMMARY OF THE INVENTION




New intraocular lens combinations (ILCs) have been disclosed. The present ILCs provide distance, near and intermediate vision through position, preferably axial position, changes in the eye. The present combinations preferably enhance the degree of accommodation achieved in spite of the movement and space limitations within the eye. One advantage of the present ILCs is the ability to standardize the prescription or optical power of the moving or accommodating lens of the ILC. Thus, the required amount of movement in the eye to achieve accommodation can be substantially the same for all patients. This greatly facilitates the design of the moving or accommodating lens. Further, with at least certain of the present ILCs, inhibition of PCO is obtained. The present ILCs are relatively straightforward in construction, can be implanted or inserted into the eye using systems and procedures which are well known in the art and function effectively with little or no additional treatments or medications being required.




In one broad aspect of the present invention, intraocular lens combinations (ILCs) comprise a first optic, second optic and a movement assembly. The first optic has a negative optical power and is adapted to be placed in a substantially fixed position in a mammalian eye. The second optic has a higher optical power than the first optic. The movement assembly is coupled to the second optic and is adapted to cooperate with the eye, for example, the zonules, ciliary muscle and capsular bag of the eye, to effect accommodating movement of the second optic in the eye.




Advantageously, the second optic has a high plus optical power to reduce the amount of movement, for example, axial movement, in the eye needed to provide accommodation for intermediate and near vision. The negative or minus optical power of the first optic compensates for the excess plus or positive optical power in the first optic. The use of such a compensating lens, that is the first optic having a negative optical power, can allow, for standardization of the optical power correction in the second optic. In other words, the optical power of the second optic, that is the movable optic, can be approximately equal from optic to optic, while the optical power of the first optic, that is the fixed optic, is adjusted from optic to optic to meet the specific vision correction needs (prescription) of each individual patient. Consequently, the required amount of movement of the second optic in the eye can be approximately the same for all patients.




The present ILCs provide accommodation, preferably an acceptable degree of accommodation, in spite of movement and space limitations in the eye. For example, the maximum theoretical amount of axial movement for a simple disc lens having an overall diameter of 11 millimeters (mm) and an optic diameter of 5 mm that undergoes 1 mm of compression in its diameter is about 1.65 mm. The amount of axial movement required for a plus 15 diopter optic to provide 2.5 diopters of additional power in the spectacle plane is about 2.6 mm. However, a plus 30 diopter optic requires only 1.2 mm of axial movement to provide 2.5 diopters of additional power in the spectacle plane. Thus, by increasing the plus power of the second optic, which is adapted for accommodating movement, a reduced amount of movement is needed to achieve higher or enhanced degrees of accommodation. The first or fixed optic preferably has a minus power to compensate for the excess plus power in the second optic.




The present ILCs preferably include first and second optics with optical powers which provide a net plus optical power. To illustrate, assume that the patient requires a plus 15 diopter correction. The first optic is provided with a minus 15 diopter optical power and the second optic with a plus 30 diopter optical power. The net optical power of this ILC is approximately the sum of minus 15 diopters and plus 30 diopters or plus 15 diopters, the desired prescription for the patient in question. The powers of the first and second optics are only approximately additive since the net power of the combination also depends on other factors including, but not limited to, the separation of the two optics, the magnitude of the power of each individual optic and its location in the eye and the like factors. Also, by adjusting the optical power of the first optic, the net optical power of the ILC can be adjusted or controlled even though the optical power of the second optic is standardized or remains the same, for example, at a plus 30 diopter optical power. By standardizing the optical power of the second optic, the amount of movement in the eye required to obtain a given level of accommodation is substantially the same, and preferably well within the space limitations in the eye, from patient to patient.




In one very useful embodiment, the movement assembly comprises a member including a proximal end region coupled to the second optic and a distal end region extending away from the second optic and adapted to contact a capsular bag of the eye. Such movement assembly may completely circumscribe the second optic or may be such as to only partially circumscribe the second optic.




The second optic preferably is adapted to be positioned in the capsular bag of the eye.




The first optic may be coupled to a fixation member, or a plurality of fixation members, adapted to assist in fixating the first optic in the eye. Each fixation member preferably has a distal end portion extending away from the first optic. In one embodiment, the distal end portion of the fixation member is adapted to be located in the capsular bag of the eye. Alternately, the distal end portion of the fixation member may be located in contact with a sulcus of the eye. As a further alternate, the distal end portion of the fixation member may be adapted to be located in an anterior chamber of the eye.




The first optic may be located posterior in the eye relative to the second optic or anterior in the eye relative to the second optic. In a useful embodiment, the first optic is adapted to be positioned in contact with the posterior wall of the capsular bag of the eye. This positioning of the first optic provides for effective compensation of the plus or positive vision correction power of the second optic. In addition, by having the first optic in contact with the posterior wall of the capsular bag, cell growth from the capsular bag onto the ILC, and in particular onto the first and second optics of the ILC, is reduced. This, in turn, reduces the risk of or inhibits posterior capsule opacification (PCO).




In one embodiment, the fixation member or members and the movement assembly are secured together, preferably permanently secured together. Thus, when inserting the ILC into the eye, a single combined structure can be inserted. This reduces the need to position the first and second optics relative to each other. Put another way, this feature allows the surgeon to very effectively and conveniently position the ILC in the eye with reduced surgical trauma to the patient.




The fixation member and movement assembly may be secured, for example, fused, together at the distal end portion of the fixation member and the distal end region of the movement assembly.




In another broad aspect of the present invention, ILCs are provided which comprise a first optic having a posterior surface adapted to be positioned in contact with a posterior wall of the capsular bag of the eye; a second optic adapted to focus light toward a retina of the eye; and a movement assembly coupled to the second optic and adapted to cooperate with the eye to effect accommodating movement of the second optic in the eye. The first optic has a substantially plano optical power or a negative optical power. These ILCs are particularly adapted to inhibit PCO.




The first optic of these combinations preferably is adapted to be placed in a substantially fixed position in the eye. The posterior surface of the first optic advantageously is configured to substantially conform to a major portion, that is, at least about 50%, of the posterior wall of the capsular bag of the eye in which the combination is placed. More preferably, the posterior surface of the first optic is configured to substantially conform to substantially all of the posterior wall of the capsular bag. Such configuration of the first optic is very useful in inhibiting cell growth from the eye onto the first and second optics and in inhibiting PCO.




In one embodiment, the first optic has a substantially plano optical power and the second optic has a far vision correction power. In an alternate embodiment, the first optic has a negative optical power and the second optic has a positive optical power, more preferably, so that the optical powers of the first and second optics provide a net plus optical power in the eye in which the combination is placed.




In a very useful embodiment, the first optic includes an anterior surface and at least one projection extending anteriorly from this anterior surface. The at least one projection is positioned to limit the posterior movement of the second optic in the eye. Thus, the movement of the second optic is effectively controlled to substantially maintain the configuration of the combination and/or to substantially maintain an advantageous spacing between the first and second optics.




The movement assembly may be structured and functions similarly to movement assembly of the previously described ILCs.




The first optic may have a fixation member or members coupled thereto. The fixation member or members are adapted to assist in fixating the first optic in the eye, that is in contact with the posterior wall of the capsular bag of the eye. In one embodiment, the first optic itself is configured and/or structured so that no fixation member or members are needed to maintain the first optic in contact with the posterior wall of the capsular bag of the eye. The first optic and the movement assembly of these ILCs may be secured together.




In general, the first and second optics of the present ILCs may be made of any suitable materials. Preferably, the first and second optics are made of polymeric materials. More preferably, the first and second optics and the movement assembly, and the fixation member(s), if any, are deformable for insertion through a small incision in the eye.




The present movement assemblies are sufficiently flexible to facilitate movement of the second optic in the eye upon being acted upon by the eye. In one very useful embodiment, the movement assembly includes a hinge assembly, preferably adapted and positioned to facilitate the accommodating movement of the second optic.




In those embodiments in which the first optic has a substantially plano optic power, the second optic preferably has a far vision correction power, more preferably such a power for infinity, in the unaccommodated state.




In a further broad aspect of the present invention, methods for inserting an ILC in an eye are provided. Such methods comprise providing an ILC in accordance with the present invention, as described herein. The ILC is placed into the eye, for example, in the capsular bag of the eye or partly in the capsular bag of the eye, using equipment and techniques which are conventional and well known in the art. The ILC is placed in a rest position in the eye, for example, a position so that the eye, and in particular the ciliary muscle and zonules of the eye, effectively cooperate with the movement assembly to move the second optic of the ILC anteriorly in the eye from the rest position to provide for positive accommodation. No treatments or medications, for example, to paralyze the ciliary muscle, to facilitate fibrosis or otherwise influence the position of the ILC in the eye, are required.




Preferably, the first and second optics and the movement assembly are deformed prior to being placed into the eye. Once the ILC is placed in the eye, and after a normal period of recovery from the surgical procedure, the ILC, in combination with the eye, provides the mammal or human wearing the ILC with effective accommodation, preferably with reduced risk of PCO. In the unaccommodated state, the ILC preferably provides the mammal or human wearing the ILC with far vision correction.




Any and all features described herein and combinations of such features are included within the scope of the present invention provided that the features of any such combination are not mutually inconsistent.











Further aspects and advantages of the present invention are set forth in the following detailed description and claims, particularly when considered in conjunction with the accompanying drawings in which like parts bear like reference numerals.




BRIEF DESCRIPTION OF THE DRAWINGS





FIG. 1

is a front plan view of an ILC in accordance with the present invention.





FIG. 2

is a cross-sectional view taken generally along line


2





2


of FIG.


1


.





FIG. 3

is a cross-sectional view of an additional ILC in accordance with the present invention.





FIG. 4

is a fragmentary sectional view of an eye in which an alternate ILC in accordance with the present invention has been implanted.





FIG. 5

is a fragmentary sectional view of an eye in which another ILC in accordance with the present invention has been implanted.





FIG. 6

is a front plan view of an intraocular lens useful in an ILC in accordance with the present invention.











DETAILED DESCRIPTION OF THE DRAWINGS




Referring now to

FIGS. 1 and 2

, an ILC according to the present invention, shown generally at


10


, includes a first optic


12


, a second optic


14


, a disc type fixation member


16


and a disc type movement assembly


18


.




The first optic


12


has substantially plano optical power and is adapted to be held in a fixed position, for example, at least partially by the fixation member


16


. When the ILC


10


is positioned in a human eye, the posterior surface


20


of first optic


12


is in contact with the inner posterior wall of the capsular bag of the eye. This positioning of optic


12


is very effective in reducing or inhibiting endothelial cell growth from the capsular bag onto the first optic


12


. In effect, the positioning of the first optic


12


against the posterior surface of the capsular bag inhibits or reduce the risk of PCO.




The second optic


14


includes a distance vision correction power. The movement assembly


18


extends radially outwardly from second optic


14


and fully circumscribes the second optic


14


. Movement assembly


18


has a proximal end region


22


which is coupled to the second optic


14


at first optic periphery


24


.




Movement assembly


18


extends radially outwardly to a distal end region


26


including a peripheral zone


28


.




Fixation member


16


includes a distal end portion


30


including a peripheral area


32


. The movement assembly


18


and fixation member


16


are fused together at the peripheral zone


28


and peripheral area


32


. Thus, the entire ILC


10


is a single unitary structure. The first optic


12


and fixation member


16


can be manufactured separately from second optic


14


and movement assembly


18


and, after such separate manufacture, the fixation member and movement assembly can be fused together. Alternately, the entire ILC


10


can be manufactured together. Also, if desired, the first optic


12


and fixation member


16


can be inserted into the eye separately from the second optic


14


and movement assembly


18


. Thus, ILC


10


can comprise a plurality of separate components.




Movement assembly


18


extends outwardly from second optic


14


sufficiently so that the distal end region


26


, and in particular the peripheral zone


28


of the distal end region, is in contact with the inner peripheral wall of the posterior capsular bag when the ILC


10


is implanted in the eye.




As best seen in

FIG. 2

, when ILC


10


is at rest, the second optic


14


is positioned vaulted anteriorly relative to the distal end region


26


of movement assembly


18


. In other words, the anterior surface


34


of second optic


14


is anterior of the anterior surface


36


of movement assembly


18


at distal end region


26


and/or the posterior surface


38


of the second optic


14


is anterior of the posterior surface


40


of the movement assembly at the distal end region.




The first and second optics


12


and


14


may be constructed of rigid biocompatible materials, such as polymethyl methacrylate (PMMA), or flexible, deformable materials, such as silicone polymeric materials, acrylic polymeric materials, hydrogel polymeric materials, and the like, which enable the optics


12


and


14


to be rolled or folded for insertion through a small incision into the eye. Although the first and second optics


12


and


14


as shown are refractive lens bodies, the present ILCs can include at least one diffractive lens body, and such embodiment is included within the scope of the present invention.




As noted previously, first optic


12


has a substantially plano or zero optical power. Second optic


14


is prescribed for the wearer of ILC


10


with a baseline or far (distance) diopter power for infinity. Thus, the wearer of ILC


10


is provided with the vision correction power of second optic


14


with little or no contribution from the first optic


12


.




The fixation member


16


and movement assembly


18


, as shown, are integral (unitary) with and circumscribe the first and second optics


12


and


14


, respectively. Alternately, fixation member


16


and/or movement assembly


18


can be mechanically or otherwise physically coupled to first optic


12


and second optic


14


, respectively. Also, the fixation member


16


and/or movement assembly


18


may only partially circumscribe first and second optics


12


and


14


, respectively, and such embodiments are included within the scope of the present invention. The fixation member


16


and movement assembly


18


may be constructed from the same or different biocompatible materials as first and second optics


12


and


14


, and preferably are made of polymeric materials, such as polypropylene silicone polymeric materials, acrylic polymeric materials, and the like. Movement assembly


18


has sufficient strength and rigidity to be effective to transfer the force from the ciliary muscle of the eye so that the second optic


14


is movable axially in the eye to effect accommodation.




Movement member


18


includes a region of reduced thickness


42


located at the proximal end region


22


. This area of reduced thickness, which completely circumscribes the second optic


14


, acts as a hinge to provide additional flexibility to the movement member


18


to extenuate or amplify the accommodating movement of second optic


14


in response to the action of the ciliary muscle and zonules.




The fixation member


16


and movement assembly


18


preferably are deformable, in much the same manner as first and second optics


12


and


14


are deformable, to facilitate passing ILC


10


through a small incision into the eye. The material or materials of construction from which fixation member


16


and movement assembly


18


are made are chosen to provide such members with the desired mechanical properties, e.g., strength and/or deformability, to meet the needs of the particular application involved.




The ILC


10


can be inserted into the capsular bag of a mammalian eye using conventional equipment and techniques, for example, after the natural crystalline lens of the eye is removed, such as by using a phacoemulsification technique. The ILC


10


preferably is rolled or folded prior to insertion into the eye, and is inserted through a small incision into the eye and is located in the capsular bag of the eye.




The ILC


10


in the eye is located in a position in the capsular bag so that the posterior surface


20


of first optic


12


is maintained in contact with the inner posterior wall of the capsular bag. As noted previously, positioning the first optic


12


in contact with the posterior wall of the capsular bag reduces the risk of or inhibits cell growth from the capsular bag onto the first optic


12


which, in turn, reduces or inhibits PCO. The ciliary muscle and zonules of the eye provide force sufficient to move axially second optic


14


sufficiently to provide accommodation to the wearer of ILC


10


.




The ILC


10


should be sized to facilitate the movement of the second optic


14


in response to the action of the ciliary muscle and zonules of the eye in which the ILC is placed.




If the ILC


10


is too large, the ciliary muscle and zonules will be inhibited from effectively contracting/relaxing so that the amount of accommodating movement will be unduly restricted. Of course, if the ILC


10


is too small, the second optic


14


will be ineffective to focus light on the retina of the eye, may cause glare and/or the movement member may not cooperate with the eye to effect the desired amount of accommodating movement. If the ILC


10


is to be included in an adult human eye, the first and second optics


12


and


14


preferably have diameters in the range of about 3.5 mm to about 7 mm, more preferably in the range of about 5 mm to about 6 mm. The ILC


10


preferably has an overall maximum diameter, with the movement assembly


18


in the unflexed or rest state, in the range of about 8 mm to about 11 mm or about 12 mm.




The present ILC


10


has the ability, in cooperation with the eye, to move the second optic


14


both posteriorly and anteriorly in the eye, to provide for both distance focus and near focus, respectively. This movement of ILC


10


advantageously occurs in response to action of the ciliary muscle and zonules, which action is substantially similar to that which effects accommodation in an eye having a natural crystalline lens. Thus, the ciliary muscle and zonules require little, if any, retraining to function in accordance with the present invention. The movement member


18


, as described herein, preferably is effective to facilitate or even enhance or extenuate the axial movement of the second optic


14


caused by the action of the ciliary muscle and zonules to provide increased degree of accommodation.





FIG. 3

illustrates an additional ILC, shown generally at


110


, in accordance with the present invention. Except as expressly described herein, ILC


110


is structured and functions similar to ILC


10


. Components of ILC


110


which correspond to components of ILC


10


are indicated by the same reference numeral increased by 100.




One primary difference between ILC


110


and ILC


10


relates to the substitution of a posterior lens structure


40


for the first optic


12


and fixation member


16


. Lens structure


40


includes a posterior face


42


which is configured to come in contact with and substantially conform to the inner posterior surface of the capsular bag of the eye in which the ILC


110


is to be placed. Thus, the surface


42


which extends around the peripheral area


44


and across the center region


46


of the lens structure


40


is adapted to come in contact with and substantially conform to the inner posterior wall of the capsular bag. Moreover, the lens structure


40


is adapted to remain in contact with this inner posterior wall of the capsular bag and to be fixed in the eye. This configuration has been found to be very effective in inhibiting cell growth from the eye onto the ILC


110


. The anterior surface


48


of lens structure


40


is configured to provide the lens structure with a substantially plano or zero optical power. Second optic


114


is prescribed for the wearer of ILC


110


with a baseline or distance or far (distance) dioptic power for infinity. Thus, the wearer of ILC


110


is provided with a vision correction power of second optic


114


with little or no contribution from the lens structure


40


.




Alternately, second optic


114


has a high plus power, for example, plus 30 diopters. The lens structure


40


, and in particular the region of the lens structure, defined by the anterior surface


48


, which extends substantially across the entire field of vision of the wearer of ILC


110


, has a minus vision correction power which is controlled to provide the correction prescription for use in the eye in which the ILC


110


is placed. For example, if this eye requires: a plus 15 diopter power, the lens structure


40


has a vision correction power of approximately minus 15 diopters so that the net vision correction power of the combination of lens structure


40


and second optic


114


, is plus 15 diopters.




The lens structure can be made from materials described previously with regard to first optic


12


and fixation member


16


.




One additional feature of lens structure


40


relates to the anteriorly extending projections


50


which extend from the base element


52


of lens structure


40


. The number of these projections


50


can range from 2 to about 6 or more. Alternately, a continuous annulus projecting anteriorly can be provided. The purpose of the projections


50


or the continuous annulus is to limit the posterior movement of the second optic


114


and movement assembly


118


. This limitation in the movement provides an additional degree of control of the ILC


110


, and prevent a collapse of the ILC


110


and maintains an advantageous degree of separation between second optic


114


and anterior surface


48


of lens structure


40


.





FIG. 4

illustrates the use of an alternate ILC in accordance with the present invention. This ILC, shown generally at


60


includes a first optic


62


, a second optic


64


and a movement assembly


66


. First optic


62


is coupled to a fixation member


68


which includes a distal end portion


70


in contact with the periphery


72


of the sulcus


73


of eye


74


. Fixation member


68


is a disk fixation member which completely circumscribes the first optic


62


. However, it should be noted that the disc fixation member


68


can be replaced by two or more filament fixation members or plate fixation members or other types of fixation members, many of which are conventional and well known in the art. Movement assembly


66


is coupled to second optic


64


and completely circumscribes the second optic. Second optic


64


is located in the capsular bag


76


of eye


74


and is vaulted anteriorly to some extent to enhance accommodating movement of the second optic.




Second optic


64


has a high plus power, for example, plus 30 diopters. The first optic


62


is a compensating negative or minus lens having a minus vision correction power which is controlled to provide the correct prescription for use in eye


74


. For example, if the eye


74


requires a plus 15 diopter power, the first optic has a vision correction power of approximately minus 15 diopters so that the net vision correction power of the combination of first optic


62


and second optic


64


is plus 15 diopters. The first optic


62


, fixation member


68


, second optic


64


and movement assembly


66


can be made from materials described previously with regard to the first optic


12


, fixation member


16


, second optic


14


and movement assembly


18


, respectively.




In the configuration shown in

FIG. 4

, the fixation member


68


is in contact with the periphery


72


of the sulcus


73


of the eye


74


. This is a relatively durable component of the eye and is effective to support the fixation member


68


in maintaining the first optic


62


in a fixed position.




The movement assembly


66


cooperates with the ciliary muscle


78


and zonules


80


of eye


74


to move the second optic


64


axially along optical axis


82


of the eye.





FIG. 5

illustrates another ILC, shown generally at


360


, in accordance with the present invention. Except as expressly described herein, ILC


360


is structured and functions similarly to ILC


60


. Components of ILC


360


which correspond to components of ILC


60


are identified by the same reference numeral increased by 300.




One primary difference between ILC


360


and ILC


60


relates to the positioning of first optic


362


. Specifically, first optic


362


is located in anterior chamber


90


of eye


374


. Fixation member


368


is coupled to the first optic


362


and extends outwardly and comes in contact with the angle


92


of eye


374


. The arrangement of first optic


362


and fixation member


368


is such that the first optic is maintained in a substantially stationary position in the anterior chamber


90


of eye


374


. The second optic


364


is adapted to be moved axially along optical axis


382


of eye


374


by the ciliary muscle


378


and zonules


380


acting on the movement assembly


366


.





FIG. 6

illustrates a still further embodiment of an intraocular lens in accordance with the present invention. This intraocular lens, shown generally at


400


includes an optic


401


and four (4) equally spaced apart movement members


403


. Each of the movement members


403


includes a distal region


405


and a proximal region


407


which is coupled to the optic


401


. A hinge, for example, a linear hinge, such as a reduced thickness area


409


, is located near the proximal end


407


of each of the movement members


403


. A linear hinge is particularly advantageous to achieve enhanced, or even substantially maximum theoretical, axial movement.




The IOL


400


can be used in place of the various second optic/movement assembly subcombinations noted above. One distinction between IOL


400


and these other subcombinations is the use of four (4) individual movement members


403


which do not totally circumscribe the optic


401


relative to the movement assemblies noted previously which fully circumscribe the second optics. It should be noted that the movement assemblies of the present ILCs can have other configurations, for example, which are effective to facilitate or even enhance the movement of the second optics.




While this invention has been described with respect to various specific examples and embodiments, it is to be understood that the invention is not limited thereto and that it can be variously practiced within the scope of the following claims.



Claims
  • 1. A system of intraocular lens combinations for a plurality of patients each requiring different vision corrections, comprising:one of a plurality of the same high plus power optics configured to cooperate with the eye and provide accommodation; and one of a plurality of optics each having a different negative power than the others and being configured to maintain a substantially fixed axial position after implantation in a patient's eye; wherein the optical powers of the high plus power and negative power optic in any one combination provide a net plus power to the combination, and wherein a magnitude of the negative power optic of any one combination is selected based on the required vision correction for a particular patient.
  • 2. The system of claim 1, wherein the high plus power optics are configured to be implanted in the capsular bag of the eye.
  • 3. The system of claim 2, wherein at least one of the plurality of negative power optics is configured to be implanted in the capsular bag of the eye in a location that is posterior with respect to the high plus power optic.
  • 4. The system of claim 1, wherein at least one of the plurality of negative power optics is configured to be implanted in contact with the sulcus of the eye.
  • 5. The system of claim 1, wherein at least one of the plurality of negative power optics is configured to be implanted in the anterior chamber of the eye.
  • 6. The system of claim 1, wherein at least one of the plurality of negative power optics is coupled to a fixation member which includes a distal end portion configured to contact a surrounding anatomical structure in the eye.
  • 7. The system of claim 6, wherein the fixation member is a disk fixation member which completely circumscribes the negative power optic.
  • 8. The system of claim 6, wherein the fixation member comprises two or more members selected from the group consisting of:filament fixation members; and plate fixation members.
  • 9. The system of claim 1, further including a movement assembly coupled to each of the high plus power optics, the movement assembly being configured to cooperate with the eye to effect accommodating axial movement of the high plus power optic.
  • 10. The system of claim 6, wherein each movement assembly comprises individual movement members which do not totally circumscribe the respective high plus power optic and include a proximal region coupled to the optic and a distal region configured to contact a surrounding anatomical structure in the eye.
  • 11. The system of claim 10, wherein each of the individual movement members includes a hinge located near the proximal region.
  • 12. The system claim 11, wherein the hinge comprises an area of reduced thickness in the movement member.
  • 13. The system of claim 1, wherein the high plus power is more than about 15 diopter.
  • 14. The system of claim 13, wherein the high plus power is about 30 diopter.
  • 15. An intraocular lens combination, comprising:a negative power optic configured to maintain a substantially fixed axial position after implantation in the capsular bag of a patient's eye; and a plus power optic formed and implanted separately from the negative power optic and configured to be implanted in the capsular bag of the eye in an anterior position relative to the negative power optic, the plus power optic configured to provide accommodation.
  • 16. The system of claim 15, wherein the negative power optic is coupled to a fixation member which includes a distal end portion configured to contact the surrounding capsular bag.
  • 17. The system of claim 16, wherein the fixation member is a disk fixation member which completely circumscribes the negative power optic.
  • 18. The system of claim 16, wherein the fixation member comprises two or more members selected from the group consisting of:filament fixation members; and plate fixation members.
  • 19. The system of claim 15, further including a movement assembly coupled to the plus power optic, the movement assembly being configured to cooperate with the capsular bag to effect accommodating axial movement of the plus power optic.
  • 20. The system of claim 19, wherein the movement assembly comprises individual movement members which do not totally circumscribe the plus power optic and include a proximal region coupled to the optic and a distal region configured to contact the surrounding capsular bag.
  • 21. The system of claim 20, wherein each of the individual movement members includes a hinge located near the proximal region.
  • 22. The system claim 21, wherein the hinge comprises an area of reduced thickness in the movement member.
  • 23. The system of claim 15, wherein the plus power is more than about 15 diopter.
  • 24. The system of claim 23, wherein the plus power is about 30 diopter.
CROSS REFERENCE TO RELATED APPLICATION

This application claims the benefit of U.S. Provisional Application No. 60/132,085 filed Apr. 30, 1999.

US Referenced Citations (139)
Number Name Date Kind
1483509 Bugbee Feb 1924 A
2129305 Feinbloom Sep 1938 A
2274142 Houchin Feb 1942 A
2405989 Beach Jun 1946 A
2511517 Spiegel Jun 1950 A
3031927 Wesley May 1962 A
3034403 Neefe May 1962 A
RE25286 DeCarle Nov 1962 E
3210894 Bentley et al. Oct 1965 A
3227507 Feinbloom Jan 1966 A
3339997 Wesley Sep 1967 A
3420006 Barnett Jan 1969 A
3431327 Tsuetaki Mar 1969 A
3482906 Volk Dec 1969 A
3542461 Girard et al. Nov 1970 A
3693301 Lemaltre Sep 1972 A
3922728 Krasnov Dec 1975 A
3932148 Krewalk, Sr. Jan 1976 A
4055378 Feneberg et al. Oct 1977 A
4062629 Winthrop Dec 1977 A
4162122 Cohen Jul 1979 A
4195919 Shelton Apr 1980 A
4199231 Evans Apr 1980 A
4210391 Cohen Jul 1980 A
4240719 Gullino et al. Dec 1980 A
4253199 Banko Mar 1981 A
4254509 Tennant Mar 1981 A
4274717 Davenport Jun 1981 A
4307945 Kitchen et al. Dec 1981 A
4315673 Guilino et al. Feb 1982 A
4316293 Bayers Feb 1982 A
4338005 Cohen Jul 1982 A
4340283 Cohen Jul 1982 A
4370760 Kelman Feb 1983 A
4377329 Poler Mar 1983 A
4402579 Poler Sep 1983 A
4404694 Kelman Sep 1983 A
4409691 Levy Oct 1983 A
4418991 Breger Dec 1983 A
4476591 Arnott Oct 1984 A
4504982 Burk Mar 1985 A
4551864 Akhavi Nov 1985 A
4560383 Leiske Dec 1985 A
4573775 Bayshore Mar 1986 A
4580882 Nuchman et al. Apr 1986 A
4596578 Kelman Jun 1986 A
4618228 Baron et al. Oct 1986 A
4618229 Jacobstein et al. Oct 1986 A
4636049 Blaker Jan 1987 A
4636211 Nielsen et al. Jan 1987 A
4637697 Freeman Jan 1987 A
4641934 Freeman Feb 1987 A
4676792 Praeger Jun 1987 A
4687484 Kaplan Aug 1987 A
4693572 Tsnetaki et al. Sep 1987 A
RE32525 Pannu Oct 1987 E
4702244 Mazzocco Oct 1987 A
4704016 DeCarle Nov 1987 A
4720286 Bailey et al. Jan 1988 A
4725278 Shearing Feb 1988 A
4752123 Blaker Jun 1988 A
4759762 Grendahl Jul 1988 A
4769033 Nordan Sep 1988 A
4790847 Woods Dec 1988 A
4813955 Achatz et al. Mar 1989 A
4830481 Futhey et al. May 1989 A
4842601 Smith Jun 1989 A
4881804 Cohen Nov 1989 A
4888012 Horn et al. Dec 1989 A
4888015 Domino Dec 1989 A
4890912 Visser Jan 1990 A
4890913 DeCarle Jan 1990 A
4892543 Turley Jan 1990 A
4898461 Portney Feb 1990 A
4906246 Grendahl Mar 1990 A
4917681 Nordan Apr 1990 A
4919663 Grendahl Apr 1990 A
4921496 Grendahl May 1990 A
4923296 Grendahl May 1990 A
4932966 Christie et al. Jun 1990 A
4932968 Caldwell et al. Jun 1990 A
4938583 Miller Jul 1990 A
4955902 Kelman Sep 1990 A
4976534 Milge et al. Dec 1990 A
4976732 Vorosmarthy Dec 1990 A
4990159 Kraff Feb 1991 A
4994082 Richards et al. Feb 1991 A
5000559 Takahashi et al. Mar 1991 A
5002382 Seidner Mar 1991 A
5019098 Mercier May 1991 A
5019099 Nordan May 1991 A
5047052 Dubroff Sep 1991 A
5071432 Baikoff Dec 1991 A
5089024 Christie et al. Feb 1992 A
5096285 Silberman Mar 1992 A
5112351 Christie et al. May 1992 A
5147397 Christ et al. Sep 1992 A
5158572 Nielsen Oct 1992 A
5166711 Portney Nov 1992 A
5166712 Portney Nov 1992 A
5171266 Wiley et al. Dec 1992 A
5173723 Volk Dec 1992 A
5192317 Kalb Mar 1993 A
5192318 Schneider et al. Mar 1993 A
5201762 Hauber Apr 1993 A
5225858 Portney Jul 1993 A
5258025 Fedorov et al. Nov 1993 A
5260727 Oksman et al. Nov 1993 A
5270744 Portney Dec 1993 A
5275623 Sarfarazi Jan 1994 A
5354335 Lipshitz et al. Oct 1994 A
5443506 Garabet Aug 1995 A
5476514 Cumming Dec 1995 A
5480428 Fedorov et al. Jan 1996 A
5489302 Skottun Feb 1996 A
5496366 Cumming Mar 1996 A
5521656 Portney May 1996 A
5562731 Cumming Oct 1996 A
5578081 McDonald Nov 1996 A
5607472 Thompson Mar 1997 A
5628795 Langerman May 1997 A
5628796 Suzuki May 1997 A
5652014 Galin et al. Jul 1997 A
5652638 Roffman et al. Jul 1997 A
5657108 Portney Aug 1997 A
5674282 Cumming Oct 1997 A
5682223 Menezes et al. Oct 1997 A
5684560 Roffman et al. Nov 1997 A
5766244 Binder Jun 1998 A
5769890 McDonald Jun 1998 A
5776191 Mazzocco Jul 1998 A
5814103 Lipshitz et al. Sep 1998 A
5843188 McDonald Dec 1998 A
5876442 Lipshitz et al. Mar 1999 A
6013101 Israel Jan 2000 A
6096078 McDonald Aug 2000 A
6176878 Gwon et al. Jan 2001 B1
6217612 Woods Apr 2001 B1
6488708 Sarfarazi Dec 2002 B2
Foreign Referenced Citations (31)
Number Date Country
3225789 Oct 1989 AU
2702117 Jul 1978 DE
3246306 Jun 1984 DE
195 01 444 Jul 1996 DE
195 01 444 Jul 1996 DE
0246216 Nov 1987 EP
0329981 Aug 1989 EP
0337390 Oct 1989 EP
0342895 Nov 1989 EP
0351471 Jan 1990 EP
0566170 Oct 1993 EP
0691109 Jan 1996 EP
0897702 Feb 1999 EP
2058391 Apr 1981 GB
2124500 Feb 1984 GB
2129155 May 1984 GB
2146791 Apr 1985 GB
2192291 Jan 1988 GB
2215076 Sep 1989 GB
2-126847 May 1990 JP
8603961 Jul 1986 WO
8700299 Jan 1987 WO
8707496 Dec 1987 WO
8902251 Mar 1989 WO
8911672 Nov 1989 WO
9416648 Aug 1994 WO
9503783 Feb 1995 WO
9615734 May 1996 WO
9625126 Aug 1996 WO
9743984 Nov 1997 WO
0134067 May 2001 WO
Non-Patent Literature Citations (7)
Entry
Menzo et al. J Cataract Refract. Surg 24, Aug. 1998 (Published in U.S.), pp1039-1049.
Fechner et al. J Cataract Refract. Surg 24, Jan. 1998 (Published in U.S.), pp 48-56.
AMO Specs, Model AC-218, 1992 (Published in U.S.), 5 pages.
Chiron Vision, Nuvita MA20, 1997 (Chiron Vision Corp. 1997), 6 pages.
Thornton, Accommodation in Pseudophakia, 25, pp. 159-162.
Video Tape “New Elliptical Acco. IOL for Cataract Surgery”, Shown at ASCRS Symposium on Apr. 10, 1999. (Video Enclosed).
Partial Program re: ASCRS Symposium, Showing Video Tape Shown Between Apr. 10-14, 1999.
Provisional Applications (1)
Number Date Country
60/132085 Apr 1999 US